Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Blood hormone levels don't accurately show brain hormone levels in males.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Low testosterone might be a common cause of hair loss in male dogs.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Finasteride effectively treats baldness but may cause sexual side effects.

Hair loss in postmenopausal woman caused by ovarian issue.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.